Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase

Previous investigations in our laboratories resulted in the discovery of a novel series of potent nucleoside inhibitors of Hepatitis C virus (HCV) NS5B polymerase bearing tetracyclic 7-substituted 7-deaza-adenine nucleobases. The planarity of such modified systems was suggested to play a role in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2012-08, Vol.20 (15), p.4801-4811
Hauptverfasser: Di Francesco, M. Emilia, Avolio, Salvatore, Pompei, Marco, Pesci, Silvia, Monteagudo, Edith, Pucci, Vincenzo, Giuliano, Claudio, Fiore, Fabrizio, Rowley, Michael, Summa, Vincenzo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4811
container_issue 15
container_start_page 4801
container_title Bioorganic & medicinal chemistry
container_volume 20
creator Di Francesco, M. Emilia
Avolio, Salvatore
Pompei, Marco
Pesci, Silvia
Monteagudo, Edith
Pucci, Vincenzo
Giuliano, Claudio
Fiore, Fabrizio
Rowley, Michael
Summa, Vincenzo
description Previous investigations in our laboratories resulted in the discovery of a novel series of potent nucleoside inhibitors of Hepatitis C virus (HCV) NS5B polymerase bearing tetracyclic 7-substituted 7-deaza-adenine nucleobases. The planarity of such modified systems was suggested to play a role in the high inhibitory potency observed. This paper describes how we envisaged to maintain the desired planarity of the modified nucleobase by means of an intra-molecular H-bond, engaging a H-bond donor atom on an appropriately substituted 7-heterocyclic residue with the adjacent amino group of the nucleobase. The success of this strategy is reflected by the identification of several novel potent nucleoside inhibitors of HCV NS5B bearing a 7-heterocyclic substituted 7-deaza-adenine nucleobase. Amongst these, the 1,2,4-oxadiazole analog 11 showed high antiviral potency against HCV replication in replicon cells and efficient conversion to the corresponding NTP in vivo, with high and sustained levels of NTP measured in rat liver following intravenous and oral administration.
doi_str_mv 10.1016/j.bmc.2012.05.067
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1500793327</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089612004543</els_id><sourcerecordid>1500793327</sourcerecordid><originalsourceid>FETCH-LOGICAL-c506t-8e7640c3248ece7a1051f74820f2bfdc9be06cc0c598f5602c2acec7acdf6a243</originalsourceid><addsrcrecordid>eNp9kcGO0zAQhiMEYrsLD8AFckHaS8LYiZ1EnJYKWKQVHMqeLWc8oa6SuNhOpfIKvDReWuDGYeTDfP8_4_mz7AWDkgGTb3ZlP2HJgfESRAmyeZStWC3roqo69jhbQSfbAtpOXmSXIewAgNcde5pdcN40IIRcZT83xzluKdiQ69mkivZgvR7zvXd78tFSyN2Qz-5AY94UW4rkHR5xtJiHpQ_RxiWSSS1D-ocutKHZzpTPC47kgjWU23lrexud_-10S3udRGneOv-8Ee_yvRuPE3kd6Fn2ZNBjoOfn9yq7__D-6_q2uPvy8dP65q5AATIWLTWyBqx43RJSoxkINjR1y2Hg_WCw6wkkIqDo2kFI4Mg1EjYazSA1r6ur7Prkm_74faEQ1WQD0jjqmdwSFBMATVdVvEkoO6HoXQieBrX3dtL-qBiohwzUTqUM1EMGCoRKGSTNy7P90k9k_ir-HD0Br8-ADqjHwesZbfjHSQ41ryBxr07coJ3S33xi7jdpUlqPMahrkYi3J4LSuQ6WvApoaUYy1hNGZZz9z6K_ADybr-o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1500793327</pqid></control><display><type>article</type><title>Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Di Francesco, M. Emilia ; Avolio, Salvatore ; Pompei, Marco ; Pesci, Silvia ; Monteagudo, Edith ; Pucci, Vincenzo ; Giuliano, Claudio ; Fiore, Fabrizio ; Rowley, Michael ; Summa, Vincenzo</creator><creatorcontrib>Di Francesco, M. Emilia ; Avolio, Salvatore ; Pompei, Marco ; Pesci, Silvia ; Monteagudo, Edith ; Pucci, Vincenzo ; Giuliano, Claudio ; Fiore, Fabrizio ; Rowley, Michael ; Summa, Vincenzo</creatorcontrib><description>Previous investigations in our laboratories resulted in the discovery of a novel series of potent nucleoside inhibitors of Hepatitis C virus (HCV) NS5B polymerase bearing tetracyclic 7-substituted 7-deaza-adenine nucleobases. The planarity of such modified systems was suggested to play a role in the high inhibitory potency observed. This paper describes how we envisaged to maintain the desired planarity of the modified nucleobase by means of an intra-molecular H-bond, engaging a H-bond donor atom on an appropriately substituted 7-heterocyclic residue with the adjacent amino group of the nucleobase. The success of this strategy is reflected by the identification of several novel potent nucleoside inhibitors of HCV NS5B bearing a 7-heterocyclic substituted 7-deaza-adenine nucleobase. Amongst these, the 1,2,4-oxadiazole analog 11 showed high antiviral potency against HCV replication in replicon cells and efficient conversion to the corresponding NTP in vivo, with high and sustained levels of NTP measured in rat liver following intravenous and oral administration.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2012.05.067</identifier><identifier>PMID: 22770556</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>2′-C-methyl-ribose ; 7-Deaza-adenine ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Antiviral Agents - chemical synthesis ; Antiviral Agents - chemistry ; Antiviral Agents - pharmacology ; antiviral properties ; Biological and medical sciences ; chemistry ; Dose-Response Relationship, Drug ; Enzyme Inhibitors - chemical synthesis ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - pharmacology ; HCV polymerase ; Hepacivirus - drug effects ; hepatitis C ; Hepatitis C virus ; intravenous injection ; liver ; Medical sciences ; Microbial Sensitivity Tests ; Molecular Structure ; Nucleoside inhhibitor ; Nucleoside triphosphate ; nucleosides ; Nucleosides - chemical synthesis ; Nucleosides - chemistry ; Nucleosides - pharmacology ; oral administration ; Pharmacology. Drug treatments ; rats ; replicon ; Replicon - drug effects ; Structure-Activity Relationship ; Viral Nonstructural Proteins - antagonists &amp; inhibitors ; Viral Nonstructural Proteins - metabolism ; Virus Replication - drug effects</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2012-08, Vol.20 (15), p.4801-4811</ispartof><rights>2012 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c506t-8e7640c3248ece7a1051f74820f2bfdc9be06cc0c598f5602c2acec7acdf6a243</citedby><cites>FETCH-LOGICAL-c506t-8e7640c3248ece7a1051f74820f2bfdc9be06cc0c598f5602c2acec7acdf6a243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bmc.2012.05.067$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26204230$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22770556$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Di Francesco, M. Emilia</creatorcontrib><creatorcontrib>Avolio, Salvatore</creatorcontrib><creatorcontrib>Pompei, Marco</creatorcontrib><creatorcontrib>Pesci, Silvia</creatorcontrib><creatorcontrib>Monteagudo, Edith</creatorcontrib><creatorcontrib>Pucci, Vincenzo</creatorcontrib><creatorcontrib>Giuliano, Claudio</creatorcontrib><creatorcontrib>Fiore, Fabrizio</creatorcontrib><creatorcontrib>Rowley, Michael</creatorcontrib><creatorcontrib>Summa, Vincenzo</creatorcontrib><title>Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>Previous investigations in our laboratories resulted in the discovery of a novel series of potent nucleoside inhibitors of Hepatitis C virus (HCV) NS5B polymerase bearing tetracyclic 7-substituted 7-deaza-adenine nucleobases. The planarity of such modified systems was suggested to play a role in the high inhibitory potency observed. This paper describes how we envisaged to maintain the desired planarity of the modified nucleobase by means of an intra-molecular H-bond, engaging a H-bond donor atom on an appropriately substituted 7-heterocyclic residue with the adjacent amino group of the nucleobase. The success of this strategy is reflected by the identification of several novel potent nucleoside inhibitors of HCV NS5B bearing a 7-heterocyclic substituted 7-deaza-adenine nucleobase. Amongst these, the 1,2,4-oxadiazole analog 11 showed high antiviral potency against HCV replication in replicon cells and efficient conversion to the corresponding NTP in vivo, with high and sustained levels of NTP measured in rat liver following intravenous and oral administration.</description><subject>2′-C-methyl-ribose</subject><subject>7-Deaza-adenine</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - chemical synthesis</subject><subject>Antiviral Agents - chemistry</subject><subject>Antiviral Agents - pharmacology</subject><subject>antiviral properties</subject><subject>Biological and medical sciences</subject><subject>chemistry</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Inhibitors - chemical synthesis</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>HCV polymerase</subject><subject>Hepacivirus - drug effects</subject><subject>hepatitis C</subject><subject>Hepatitis C virus</subject><subject>intravenous injection</subject><subject>liver</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Molecular Structure</subject><subject>Nucleoside inhhibitor</subject><subject>Nucleoside triphosphate</subject><subject>nucleosides</subject><subject>Nucleosides - chemical synthesis</subject><subject>Nucleosides - chemistry</subject><subject>Nucleosides - pharmacology</subject><subject>oral administration</subject><subject>Pharmacology. Drug treatments</subject><subject>rats</subject><subject>replicon</subject><subject>Replicon - drug effects</subject><subject>Structure-Activity Relationship</subject><subject>Viral Nonstructural Proteins - antagonists &amp; inhibitors</subject><subject>Viral Nonstructural Proteins - metabolism</subject><subject>Virus Replication - drug effects</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kcGO0zAQhiMEYrsLD8AFckHaS8LYiZ1EnJYKWKQVHMqeLWc8oa6SuNhOpfIKvDReWuDGYeTDfP8_4_mz7AWDkgGTb3ZlP2HJgfESRAmyeZStWC3roqo69jhbQSfbAtpOXmSXIewAgNcde5pdcN40IIRcZT83xzluKdiQ69mkivZgvR7zvXd78tFSyN2Qz-5AY94UW4rkHR5xtJiHpQ_RxiWSSS1D-ocutKHZzpTPC47kgjWU23lrexud_-10S3udRGneOv-8Ee_yvRuPE3kd6Fn2ZNBjoOfn9yq7__D-6_q2uPvy8dP65q5AATIWLTWyBqx43RJSoxkINjR1y2Hg_WCw6wkkIqDo2kFI4Mg1EjYazSA1r6ur7Prkm_74faEQ1WQD0jjqmdwSFBMATVdVvEkoO6HoXQieBrX3dtL-qBiohwzUTqUM1EMGCoRKGSTNy7P90k9k_ir-HD0Br8-ADqjHwesZbfjHSQ41ryBxr07coJ3S33xi7jdpUlqPMahrkYi3J4LSuQ6WvApoaUYy1hNGZZz9z6K_ADybr-o</recordid><startdate>20120801</startdate><enddate>20120801</enddate><creator>Di Francesco, M. Emilia</creator><creator>Avolio, Salvatore</creator><creator>Pompei, Marco</creator><creator>Pesci, Silvia</creator><creator>Monteagudo, Edith</creator><creator>Pucci, Vincenzo</creator><creator>Giuliano, Claudio</creator><creator>Fiore, Fabrizio</creator><creator>Rowley, Michael</creator><creator>Summa, Vincenzo</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope></search><sort><creationdate>20120801</creationdate><title>Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase</title><author>Di Francesco, M. Emilia ; Avolio, Salvatore ; Pompei, Marco ; Pesci, Silvia ; Monteagudo, Edith ; Pucci, Vincenzo ; Giuliano, Claudio ; Fiore, Fabrizio ; Rowley, Michael ; Summa, Vincenzo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c506t-8e7640c3248ece7a1051f74820f2bfdc9be06cc0c598f5602c2acec7acdf6a243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>2′-C-methyl-ribose</topic><topic>7-Deaza-adenine</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - chemical synthesis</topic><topic>Antiviral Agents - chemistry</topic><topic>Antiviral Agents - pharmacology</topic><topic>antiviral properties</topic><topic>Biological and medical sciences</topic><topic>chemistry</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Inhibitors - chemical synthesis</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>HCV polymerase</topic><topic>Hepacivirus - drug effects</topic><topic>hepatitis C</topic><topic>Hepatitis C virus</topic><topic>intravenous injection</topic><topic>liver</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Molecular Structure</topic><topic>Nucleoside inhhibitor</topic><topic>Nucleoside triphosphate</topic><topic>nucleosides</topic><topic>Nucleosides - chemical synthesis</topic><topic>Nucleosides - chemistry</topic><topic>Nucleosides - pharmacology</topic><topic>oral administration</topic><topic>Pharmacology. Drug treatments</topic><topic>rats</topic><topic>replicon</topic><topic>Replicon - drug effects</topic><topic>Structure-Activity Relationship</topic><topic>Viral Nonstructural Proteins - antagonists &amp; inhibitors</topic><topic>Viral Nonstructural Proteins - metabolism</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Di Francesco, M. Emilia</creatorcontrib><creatorcontrib>Avolio, Salvatore</creatorcontrib><creatorcontrib>Pompei, Marco</creatorcontrib><creatorcontrib>Pesci, Silvia</creatorcontrib><creatorcontrib>Monteagudo, Edith</creatorcontrib><creatorcontrib>Pucci, Vincenzo</creatorcontrib><creatorcontrib>Giuliano, Claudio</creatorcontrib><creatorcontrib>Fiore, Fabrizio</creatorcontrib><creatorcontrib>Rowley, Michael</creatorcontrib><creatorcontrib>Summa, Vincenzo</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Di Francesco, M. Emilia</au><au>Avolio, Salvatore</au><au>Pompei, Marco</au><au>Pesci, Silvia</au><au>Monteagudo, Edith</au><au>Pucci, Vincenzo</au><au>Giuliano, Claudio</au><au>Fiore, Fabrizio</au><au>Rowley, Michael</au><au>Summa, Vincenzo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2012-08-01</date><risdate>2012</risdate><volume>20</volume><issue>15</issue><spage>4801</spage><epage>4811</epage><pages>4801-4811</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>Previous investigations in our laboratories resulted in the discovery of a novel series of potent nucleoside inhibitors of Hepatitis C virus (HCV) NS5B polymerase bearing tetracyclic 7-substituted 7-deaza-adenine nucleobases. The planarity of such modified systems was suggested to play a role in the high inhibitory potency observed. This paper describes how we envisaged to maintain the desired planarity of the modified nucleobase by means of an intra-molecular H-bond, engaging a H-bond donor atom on an appropriately substituted 7-heterocyclic residue with the adjacent amino group of the nucleobase. The success of this strategy is reflected by the identification of several novel potent nucleoside inhibitors of HCV NS5B bearing a 7-heterocyclic substituted 7-deaza-adenine nucleobase. Amongst these, the 1,2,4-oxadiazole analog 11 showed high antiviral potency against HCV replication in replicon cells and efficient conversion to the corresponding NTP in vivo, with high and sustained levels of NTP measured in rat liver following intravenous and oral administration.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>22770556</pmid><doi>10.1016/j.bmc.2012.05.067</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2012-08, Vol.20 (15), p.4801-4811
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_1500793327
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects 2′-C-methyl-ribose
7-Deaza-adenine
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Antiviral Agents - chemical synthesis
Antiviral Agents - chemistry
Antiviral Agents - pharmacology
antiviral properties
Biological and medical sciences
chemistry
Dose-Response Relationship, Drug
Enzyme Inhibitors - chemical synthesis
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - pharmacology
HCV polymerase
Hepacivirus - drug effects
hepatitis C
Hepatitis C virus
intravenous injection
liver
Medical sciences
Microbial Sensitivity Tests
Molecular Structure
Nucleoside inhhibitor
Nucleoside triphosphate
nucleosides
Nucleosides - chemical synthesis
Nucleosides - chemistry
Nucleosides - pharmacology
oral administration
Pharmacology. Drug treatments
rats
replicon
Replicon - drug effects
Structure-Activity Relationship
Viral Nonstructural Proteins - antagonists & inhibitors
Viral Nonstructural Proteins - metabolism
Virus Replication - drug effects
title Synthesis and antiviral properties of novel 7-heterocyclic substituted 7-deaza-adenine nucleoside inhibitors of Hepatitis C NS5B polymerase
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A11%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20antiviral%20properties%20of%20novel%207-heterocyclic%20substituted%207-deaza-adenine%20nucleoside%20inhibitors%20of%20Hepatitis%20C%20NS5B%20polymerase&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Di%20Francesco,%20M.%20Emilia&rft.date=2012-08-01&rft.volume=20&rft.issue=15&rft.spage=4801&rft.epage=4811&rft.pages=4801-4811&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2012.05.067&rft_dat=%3Cproquest_cross%3E1500793327%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1500793327&rft_id=info:pmid/22770556&rft_els_id=S0968089612004543&rfr_iscdi=true